Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07419841 |
| Title | A Phase 1 Study of the Safety and Tolerability of CTX-10726 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Compass Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Nebraska Cancer Specialists | RECRUITING | Omaha | Nebraska | 68130 | United States | Details |
| START New York | RECRUITING | Lake Success | New York | 11042 | United States | Details |
| Prisma Health Cancer Institute | RECRUITING | Greenville | South Carolina | 29605 | United States | Details |
| SCRI Oncology Partners | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |